I started Convalesce licensing out a technology I developed in my doctoral thesis. We have developed a brain mimetic biomaterial that can radically change stem cell-based therapies for the brain and spine. We at Convalesce are now spearheaded to make stem cell-based therapeutics a reality for neuro-degenerative conditions. Participated and won business competitions in India and Switzerland. Qualified for the leading biotech accelerator, IndieBio in San Francisco in their 7th cohort. During IndieBio de-risked the business in terms of regulatory and manufacturing strategies. Completed key proof-of-concept study in animal models. Initiated dialogues for strategic partnerships with pharmaceutical companies.
Listed skills include Protein Purification, Pcr, Molecular Biology, Rt Pcr, and 19 others.